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Abstract: It is well established that selective activation of group I metabotropic glutamate (mGlu)
receptors induces LTD of synaptic transmission at Schaffer collateral-CA1 synapses. In contrast, appli-
cation of 1S,3R-ACPD, a mixed agonist at group I and group II mGlu receptors, induces LTP. Using
whole-cell recordings from CA1 pyramidal cells and field recordings in the hippocampal CA1 region,
we investigated the specific contribution of group II mGlu receptors to synaptic plasticity at Schaffer
collateral-CA1 synapses in acute slices of adult mice. Pharmacological activation of group II mGlu re-
ceptors (mGlu2 and mGlu3 receptors) with the specific agonist LY354740 in conjunction with electrical
stimulation induced postsynaptic LTP. This form of plasticity requires coactivation of NMDA receptors
(NMDARs). Group II mGlu receptor activation led to PKC-dependent phosphorylation of the GluN1
subunit. We found that both synaptic and extrasynaptic NMDARs, which are differentially modulated
by mGlu2 and mGlu3 receptors, contribute to LTP induction. Furthermore, LTP initiated by activation
of group II mGlu receptors was not occluded by LTP induced with high-frequency trains of stimuli.
However, the phosphorylation of NMDARs mediated by group II mGlu receptor activation led to a
priming effect that enhanced subsequent high-frequency stimulation-induced LTP. These findings reveal
a novel metaplastic mechanism through which group II mGlu receptors modulate synaptic function at
the Schaffer collateral input to CA1 pyramidal cells, thereby lowering the threshold to induce plasticity.
SIGNIFICANCE STATEMENT: The group II metabotropic glutamate (mGlu II) receptors exert a well
characterized action on presynaptic neuron terminals to modulate neurotransmitter release. Here, we
show that these receptors also have postsynaptic effects in promoting the induction of synaptic plasticity.
Using an electrophysiological approach including field and whole-cell patch recording in hippocampi from
wild-type and transgenic mice, we show that activation of group II mGlu receptors enhances NMDA
receptor (NMDAR)-mediated currents through PKC-dependent phosphorylation. This priming of NM-
DARs lowers the threshold for the induction of LTP of synaptic transmission. These findings may also
provide new insights into the mechanisms through which drugs targeting mGlu II receptors alleviate
hypoglutamatergic conditions such as those occurring in certain brain disorders such as schizophrenia.
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Activation of Group II Metabotropic Glutamate Receptors
Promotes LTP Induction at Schaffer Collateral-CA1
Pyramidal Cell Synapses by Priming NMDA Receptors
Nadia Rosenberg,1,2Urs Gerber,1,2 and Jeanne Ster3
1Brain Research Institute and 2Neuroscience Center Zurich, University of Zurich, CH-8057 Zurich, Switzerland; and 3Institut de Ge´nomique Fonctionnelle,
Centre National de la Recherche Scientifique, UMR 5203, 34094 Montpellier, France Cedex 5
It is well established that selective activation of group Imetabotropic glutamate (mGlu) receptors induces LTD of synaptic transmission
at Schaffer collateral–CA1 synapses. In contrast, application of 1S,3R-ACPD, a mixed agonist at group I and group II mGlu receptors,
induces LTP. Usingwhole-cell recordings fromCA1 pyramidal cells and field recordings in the hippocampal CA1 region, we investigated
the specific contributionof group IImGlu receptors to synaptic plasticity at Schaffer collateral–CA1 synapses in acute slices of adultmice.
Pharmacological activation of group II mGlu receptors (mGlu2 andmGlu3 receptors) with the specific agonist LY354740 in conjunction
with electrical stimulation inducedpostsynaptic LTP. This formof plasticity requires coactivationofNMDAreceptors (NMDARs). Group
IImGlu receptor activation led to PKC-dependent phosphorylation of the GluN1 subunit.We found that both synaptic and extrasynaptic
NMDARs,whicharedifferentiallymodulatedbymGlu2andmGlu3 receptors, contribute toLTP induction. Furthermore, LTP initiatedby
activation of group II mGlu receptors was not occluded by LTP induced with high-frequency trains of stimuli. However, the phosphory-
lation of NMDARs mediated by group II mGlu receptor activation led to a priming effect that enhanced subsequent high-frequency
stimulation-induced LTP. These findings reveal a novel metaplastic mechanism through which group II mGlu receptors modulate
synaptic function at the Schaffer collateral input to CA1 pyramidal cells, thereby lowering the threshold to induce plasticity.
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Introduction
Group II metabotropic glutamate receptors (mGlu II) compris-
ing the mGlu2 and the mGlu3 receptor subtypes are present
throughout the brain with high expression in the hippocampus
(Tamaru et al., 2001). Their role as presynaptic autoreceptors in
the negative feedback regulation of glutamate release is well es-
tablished at the mossy fiber–CA3 synapse (Kamiya et al., 1996;
Scanziani et al., 1997), at CA1 synapses onto subicular neurons
(Kintscher et al., 2012), and at the lateral perforant path (Aksoy-
Aksel and Manahan-Vaughan, 2015) and medial perforant path
between the entorhinal cortex andCA1 pyramidal cells (Macek et
al., 1996; Capogna, 2004). More recently, postsynaptic actions
have been characterized including the initiation by somatoden-
dritic mGlu3 receptors of theta oscillations in the hippocampal
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Significance Statement
The group II metabotropic glutamate (mGlu II) receptors exert a well characterized action on presynaptic neuron terminals to
modulate neurotransmitter release. Here, we show that these receptors also have postsynaptic effects in promoting the induction
of synaptic plasticity. Using an electrophysiological approach including field and whole-cell patch recording in hippocampi from
wild-type and transgenicmice, we show that activation of group IImGlu receptors enhancesNMDA receptor (NMDAR)-mediated
currents through PKC-dependent phosphorylation. This priming of NMDARs lowers the threshold for the induction of LTP of
synaptic transmission. These findingsmay also provide new insights into themechanisms throughwhich drugs targetingmGlu II
receptors alleviate hypoglutamatergic conditions such as those occurring in certain brain disorders such as schizophrenia.
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CA3 area (Ster et al., 2011) and the activation by mGlu2 rece-
ptors of a dendritic shunt in dentate granule cells involving a
G-protein-coupled inwardly rectifying potassium conductance
(Brunner et al., 2013). mGlu II receptors are also implicated in
learning and synaptic plasticity. Spatial memory encoding in rats
is deficient after blockade of mGlu II receptors (Altinbilek and
Manahan-Vaughan, 2009). In addition, working memory and
performance on a spatial novelty task relying on the explorative
drive of the animal are impaired in double knock-out (KO)
(GRM2/3) mice (Lyon et al., 2011).
At the mossy fiber–CA3 synapse, activation of mGlu2 recep-
tors at presynaptic terminals induces LTD (Yokoi et al., 1996),
presumably by inhibition of adenylyl cyclase (Conn and Pin,
1997). However, at Schaffer collateral synapses onto CA1 pyra-
midal cells, the roles of mGlu II receptors in synaptic plasticity
remain unclear. Earlier studies reported that application of the
metabotropic agonist 1S,3R-ACPD induces LTP at these syn-
apses (Bashir et al., 1993; Bortolotto et al., 1994), but 1S,3R-
ACPDwas later shown to be an agonist at bothmGlu I andmGlu
II receptors. Selective activation ofmGlu I receptors induces LTD
at these synapses (Palmer et al., 1997; Fitzjohn et al., 1999; Huber
et al., 2000). We therefore hypothesized that the LTP observed in
response to a mixed agonist is mediated primarily by mGlu II
receptors. Indeed, our experimental results indicate that activa-
tion of mGlu II receptors leads to the phosphorylation of NMDA
receptors, which facilitates the induction of LTP.
Materials andMethods
Tissue preparation.Acute slices were prepared from juvenilemalemice at
postnatal day 21 (P21) to P27 following a protocol approved by the
Veterinary Department of the Canton of Zurich (approval ID: 81–2014).
Transgenic animals used in our experiments were mGlu2/ (RRID:
MGI:3629946) (Morishima et al., 2005) and mGlu3/ (Corti et al.,
2007) mice. Mice were decapitated and brains quickly removed in ice-
cold artificial CSF (ACSF) solution containing the following (inmM): 125
NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaCHCO3, 1 MgCl2, 2 CaCl2, and 10
glucose, pH 7.4, equilibrated with 95% O2 and 5% CO2. Next, 350 m
(for field) or 300 m (for patch) thick sagittal acute slices were prepared
with a vibratome (HM650V;Microm International) in the same ice-cold
ACSF. Sections were incubated in ASCF for 20min at 34°C and then kept
at room temperature for at least 1 h before recording.
Drugs. D-()-2-amino-5-phosphonopentanoic acid (D-AP5), NBQX
disodium salt, LY341495, Ro 25–6981 maleate salt, MK-801, genistein,
and cyclopiazonic acid (CPA) were from Abcam. LY354740, bisindolyl-
maleide II, chelerytherine chloride, and H89 dihydrochloride were from
Tocris Bioscience. N-ethyl-maleimide (NEM) was from Sigma-Aldrich
and NVP-AAM077-NX-6 was a generous gift from Novartis Pharma.
Electrophysiology. Recordings were obtained using an Axopatch 200B
amplifier (Molecular Devices). Acute slices were transferred to a record-
ing chambermounted on an uprightmicroscope (Axioscope FS1; Zeiss).
Slices were superfused continuously at 2 ml/min with ACSF at 28°C.
Single test pulses were delivered to the Schaffer collaterals (stratum ra-
diatum of CA1) at 0.05 Hz via a monopolar electrode. Input–output
curves were generated for each slice and the stimulation intensity was
adjusted to 40–50% of the maximum response. After at least 10 min of
stable baseline fEPSPs, LTP was induced either by bath application of
LY354740 (1 M for 10 min), a specific group II mGlu receptor agonist,
or by 3 trains of 100 Hz stimulation of 1 s duration separated by 20 s of
high-frequency stimulation (HFS). Alternatively, after a 5 min baseline,
slices were pretreated with a group II mGlu receptor antagonist
LY341495 (4 M), a membrane permeable blocker of G-proteins, NEM
(100 M), or an NMDAR antagonist, D-AP5 (40 M) for 10 min before
coapplication with LY354740. Slices were pretreated with a PKA antag-
onist, H89 (10 M), a GluN2A antagonist, NVP-AAM077 (0.1 M), or a
GluN2B antagonist, Ro25–69813 (3 M), for 20 min before coapplica-
tion with LY354740 and were pretreated with PKC antagonists, either
bisindolylmaleide II (1 M) or chelerytherine (10 M), or a protein ty-
rosine kinase inhibitor, genistein (30 M), for 25 min before coapplica-
tion with LY354740. The use-dependent NMDAR blocker MK-801 (40
M) was bath applied for 20 min while stimulating at 0.05 Hz and then
washed out for 10 min before applying LY354740 for 10 min. Slices were
incubated for 2 h in the Ca2-ATPase inhibitor CPA (20 M) before
coapplicationwithKCl (100mM) for 5min.CPAwas thenwashed out for
10 min before bath application of LY354740 (1 M for 10 min). Evoked
responses were analyzed by measuring the slope of individual fEPSPs.
The slopes from three sequential sweeps were averaged. All slopes were
normalized to the average slope calculated during the predrug period
(percentage of baseline).
Whole-cell recordingswere performed by using the blind patch-clamp
method (Blanton et al., 1989). Recordings from CA1 pyramidal neurons
were obtained with patch pipettes (5–6 M) filled with intracellular
solution containing the following (in mM): 135 K-gluconate, 5 KCl, 10
HEPES, 1 EGTA, 5 phosphocreatine (CrP), 2 MgATP, and 0.4 NaGTP,
pH 7.2. Membrane potentials were corrected for junction potentials.
EPSCs were recorded at 70 mV and EPSPs were recorded in current-
clamp mode at resting potential. After at least 5 min of stable baseline
recording, LTP was induced by bath application of LY354740 for 10 min
and then washed out for 30 min.
NMDA-mediated EPSCs were recorded at 70 mV with ACSF con-
taining a low magnesium concentration (0.1 mM) and in presence of an
AMPA receptor antagonist (NBQX, 25 M). The amplitudes from three
sequential sweeps were averaged. Input resistance was either monitored
continuously or calculated by measuring the amplitude of the steady-
state current evoked during a5mV voltage step delivered 50ms before
the test stimulation. Cells were excluded if a change of 20% occurred
during the recording.
All data were analyzed offline using pClamp 9 software (Molecular
Devices) and are reported as the mean  SEM. Statistical comparisons
were made using two-tailed unpaired or paired Student’s t tests. Differ-
ences were considered significant at p 0.05.
Western blots. Acute slices were prepared as described in the tissue
preparation section. Slices were removed from the recording chamber 10
min after the application of LY354740 in the bath or 5min afterHFS. The
CA1 region was isolated under a binocular dissection microscope. CA1
tissue was flash frozen in liquid nitrogen and stored at 80°C before
extraction in 50 l of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 0.1% SDS, 1%NP-40, and 0.5% sodium deoxycholate) containing
protease inhibitor mixture (1:200), PMSF (1:500), and phosphatase in-
hibitor 2 and 3 (1:200). After homogenization of samples, sonication for
10 min at 4°C, and centrifugation for 10 min at 13,000  g at 4°C, the
supernatant was collected in Eppendorf tubes. Hippocampal proteins
(20 g) were resolved by electrophoresis on an 8% polyacrylamide gel
and transferred to nitrocellulose membranes. Membranes were then in-
cubated in a blocking solution containing 5%Western blocking solution
(Roche) in TBST 0.05% (Tris-base 0.1 M, NaCl 1.5 M and 0.05% Tween
20, pH 8.0) for 2 h at room temperature and incubated in primary anti-
bodies overnight at 4°C. The following antibodies were used; rabbit anti-
GluN1 phospho S896 (1:1000, RRID:AB_1310496; Abcam) and rabbit
anti-GAPDH (1:1000, RRID:AB_561053; Cell Signaling Technology).
An antibody-blocking peptide against the rabbit anti-GluN1 phospho
S896 antibody was used to confirm its specificity (1:100, ab203399; Ab-
cam). After 4 washes of 20 min in TBST, membranes were incubated for
1 h at room temperature with a secondary antibody (goat anti-rabbit,
IRDye 680 nm, 1:10000, Li-Cor Biosciences). Protein signal and intensity
were detected by infrared fluorescence using an Odyssey IR scanner (Li-
Cor Biosciences). Bands were quantified with ImageJ software and nor-
malized to GAPDH values.
Results
Group II mGlu-receptor-dependent LTP at Schaffer
collateral–CA1 synapses
Because selective activation of mGlu I receptors in the CA1 area
of hippocampus induces LTD (Palmer et al., 1997; Fitzjohn et al.,
1999), but coactivation of mGlu I and II receptors with the non-
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selective agonist ACPD induces LTP (Bashir et al., 1993; Borto-
lotto et al., 1994), we hypothesized that selective activation of
group IImGlu receptorsmay be sufficient to induce LTP. Indeed,
bath application of LY354740 (LY35, 1 M, 10 min), a highly
selective agonist of mGlu II receptors, induced a significant po-
tentiation of theCA1 fEPSP (to 137.1 6.1%, p	 0.0004,n	 12;
Fig. 1A,C) in acute slices from adult mouse. Application of the
mGlu II receptor antagonist LY341495 (4 M) (Schoepp et al.,
1999) bath applied for 20 min before and during LY354740 ap-
plication prevented LTP (94.2  9.2%, p 	 0.55, n 	 6; Fig.
1A,C), confirming that this form of LTP is initiated by mGlu II
receptor activation.
mGlu II receptors can couple to Gi/o-proteins to decrease ac-
tivity of adenylyl cyclase (Niswender and Conn, 2010).We inves-
tigated whether perturbing this classical pathway would inhibit
LTP. Blocking G-proteins with bath-applied NEM (100 M, 10
min) prevented LTP (96.5 10%, p	 0.0005,n	 4; Fig. 1B), but
the PKA inhibitor H89 (10 M, 20 min) only partially reduced
LTP (112.5 4.6%, p	 0.0151, n	 8; Fig. 1C), suggesting that
an additional signaling pathway contributes tomGlu II-receptor-
induced LTP. Previous work has shown that stimulation ofmGlu
II receptors can also activate tyrosine kinases (Trepanier et al.,
2013) and PKC (Otani et al., 2002; Tyszkiewicz et al., 2004). We
found that mGlu II-receptor-induced LTP was not affected by
inhibiting tyrosine kinase with genistein (30M, 30min; 121.8
3.4%, p	 0.29, n	 8; Fig. 1C), but was prevented in the presence
of either of two antagonists for PKC, bisindolylmaleimide (1M,
20 min, 101.8 6.1%, p	 0.0003, n	 6) and chelerythrine (10
M, 20 min, 89.5 4.5%, p 0.0001, n	 6) (Fig. 1B,C). Acti-
vation of PKC isoforms (Toullec et al., 1991) is calcium depen-
dent. Because the turnover of phosphoinositides leads to
activation of PKC and to the production of IP3, which subse-
quently induces release calcium stores (Nishizuka, 1986), we
testedwhether intracellular release of calcium storeswas involved
in this signaling pathway. mGlu II-dependent LTP was reduced
significantly when calcium stores were depleted after treatment
with CPA, a Ca2-ATPase inhibitor (20 M, 1 h: 109.2 4.7%,
p	 0.0041, n	 7; Fig. 1C). The inhibitors alone had no effect on
Figure1. Characterizationof transductionpathwaysmediatinggroup IImGlu-receptor-inducedLTPat theSchaffer collateral–CA1pyramidal cell synapse.A, fEPSPs evoked inCA1pyramidal cells
by stimulation of Schaffer collaterals at low freuency (0.05 Hz) undergo LTP after activation of group II mGlu receptors with bath-applied LY354740 (1M, 10 min). LTP is prevented by LY341495
(4M, 10min) a selective group II mGlu receptor antagonist. The inset shows representative traces (averages of six sweeps) before (1) and after (2) drug application. B, Induction of LTP is blocked
by NEM (100M, 10min), amembrane-permeable blocker of G-proteins, and by bisindolylmaleimide (1M, 20min), a PKC antagonist. Inset, Representative traces (averages of six sweeps) before
(1) and after (2) drug application. Scale bars, 0.5mV and 10ms. C, Quantification of fEPSP slope changes under a variety of pharmacological conditions (LY354740 vs LY354740 LY341495: **p
0.01, 2-tailed unpaired Student’s t test). The antagonists NEM (100M, 10 min), bisindolylmaleimide (1M, 20 min), chelerytherine (10M, 20 min), CPA (20M), H89 (10M, 20 min), and
genistein (30M, 30 min) were all applied in combination with LY354740 (1M, 10 min). ****p 0.0001, *p 0.05 indicates significantly different from slices treated only with LY354740
(ANOVA followed by Tukey’s post hoc test; F(6, 42)	 8.642).D, Paired-pulse ratio (PPR) of evoked fEPSPs (interstimulus interval	 50ms, averages of six sweeps) after LTP induction. Scale bars, 0.5
mV and 10 ms. E, PPR is not modified significantly (two-tailed paired Student’s t test) after application of LY354740, consistent with a postsynaptic mechanism of LTP.
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baseline transmission. These data suggest that mGlu II-receptor-
dependent LTP involves a noncanonical signaling pathway in-
volving the release of intracellular calcium stores and PKC
activation.
In the hippocampus, mGlu II receptors exhibit both presyn-
aptic and postsynaptic expression (Petralia et al., 1996; Shige-
moto et al., 1997; Tamaru et al., 2001).We observed no difference
in the paired-pulse ratio recorded under baseline conditions (2
0.2; Fig. 1D,E) and during stable LTP at 60min after wash-out of
LY354740 (1.9  0.2, p 	 0.53, n 	 6; Fig. 1D,E). We thus
conclude that the mGlu II receptors mediating LTP in CA1 pyra-
midal cells are localized postsynaptically.
mGlu II-receptor-dependent LTP requires activation
of NMDARs
Wenoted that pharmacological activation ofmGlu II receptors in
the absence of Schaffer collateral stimulation at 0.05 Hz failed to
induce LTP (with synaptic stimulation: 134.1 6.3%; no stimu-
lation: 96.9 9.2%, p	 0.001, n	 6; Fig. 2A,B). Furthermore,
bath application of the specific NMDAR antagonist D-AP5
(40 M) 10 min before and during LY354740 application pre-
vented LTP (98 5.3%, p	 0.0004, n	 6; Fig. 2A,B), demon-
strating that this form of metabotropic plasticity was dependent
on the activation of NMDARs.
The requirement of NMDAR activation was also apparent in
experiments in which the effect of mGlu II receptor activation on
LTP induction was compared in CA1 pyramidal cells recorded
either in current-clamp mode at resting potential or in voltage-
clampmode at70mV. In current-clampmode, Schaffer collat-
eral stimulation at 0.05 Hz evoked sufficient depolarization to
alleviate magnesium block from NMDAR channels, allowing
LTP (139.3  13%, p 	 0.019, n 	 8; Fig. 2C,D). In contrast,
voltage clamping the soma of CA1 pyramidal cells at70mVdid
not permit an NMDAR-mediated response sufficient to induce
LTP (99.6 6.8%, p	 0.94, n	 5; Fig. 2C,D).
Next we investigated whether mGlu II receptor activation
modulates NMDAR function. NMDAR-mediated EPSCs were
evoked in CA1 pyramidal cells voltage clamped at70mV in the
presence of lowmagnesium (0.1mM) andNBQX(25M, 10min)
to blockAMPA/kainate receptors. Under these conditions, appli-
cation of LY354740 (1 M, 10 min) resulted in a significant in-
crease in amplitude of NMDA EPSCs within 2min of addition to
the bath (126.9 7%, p	 0.0018, n	 8; Fig. 2E,F), an effect that
was, however, reversed within 2 min of agonist wash-out. This
Figure 2. Induction of LTP by group II mGlu receptor activation requires NMDAR activation. A, fEPSPs recorded in the stratum radiatum express LTP only if group II mGlu receptor activation
(LY354740, 1M, 10min) occurs concomitantlywith repetitive Schaffer collateral stimulation (0.05Hz). LTP is prevented by blockingNMDARs (D-AP5, 40M, 10min). Insets, Representative traces
(averages of six sweeps) before (1) and after (2) drug application. Scale bars, 0.5mVand10ms.B, Quantification of fEPSP slope changes under the conditions presented inA (no stimulation, D-AP5).
****p0.0001, *p0.05 indicates significantly different fromslices treatedonlywith LY354740 (ANOVA followedby Tukey’spost hoc test; F(2, 18)	14.23).C,Whole-cell patch-clamp recordings
of responses evokedby Schaffer collateral stimulation showpotentiation by activation of group IImGlu receptors during experiments in current-clampmode, but not in voltage-clampmode at70
mV, a potential at which NMDARs are blocked significantly bymagnesium. Insets, Representative averaged traces. Scale bars, 10mV/20 pA and 5ms.D, Quantification of EPSPs and EPSCs showing
LY354740-induced LTP only in current-clampmode, two-tailed paired Student’s t test. E, Pharmacologically isolatedNMDA currents (NBQX, 25M, 10min) evoked by Schaffer collateral stimulation
at a holding potential of70 mV with low extracellular magnesium (0.1 mM) are potentiated in response to activation of group II mGlu receptors (LY354740, 1M, 10 min). NMDAR-mediated
currents are not potentiated if PKC is blocked (bisindolylmaleimide, 1M, 20 min). Insets, Representative traces (averages of six sweeps) before (1) and after (2) drug application and after 40M
D-AP5 (3) to confirm the selective activation of NMDARs. Scale bars, 20ms and 20 pA. F, Quantification of EPSCs before, during, and after application of LY354740 in control conditions andwhen PKC
is blocked. ****p 0.0001, *p 0.05 indicates significantly different from the baseline (ANOVA followed by Tukey’s post hoc test; LY35: F(2, 17)	 100.3; LY35 bisindolylmaleimide; F(2, 15)	
225.7). G, Western blots showing phosphorylation at serine 896 of the GluN1 subunit (GluN1 p-S896) in control conditions after application of 1M LY354740 alone or in combination with 1M
bisindolylmaleimide. The specificity of the primary antibody against GluN1 p-S896 was confirmed by addition of an antibody-blocking peptide. The protein ladder indicates molecular weight
markers (M) in kDa. H, Protein quantification reveals increased phosphorylation at GluN1 p-S896 after activation of group II mGlu receptors. This effect is blocked by the PKC antagonist. ****p
0.0001, *p 0.05 indicates significantly different from the control (ANOVA followed by Tukey’s post hoc test; F(2, 16)	 4.119).
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enhancement of the NMDAR-mediated EPSC was no longer ob-
served after blocking PKC (bisindolylmaleimide, 1 M, 20 min;
96.3  5.2%, p 	 0.7, n 	 6; Fig. 2E,F). At the end of the
experiments, application of D-AP5 (40 M, 5 min) abolished
EPSCs, confirming their mediation by NMDARs. A study in pre-
frontal cortical neurons has shown that activation of mGlu II
receptors increases NMDAR-mediated currents through a pro-
cess involving phosphorylation of the GluN1NMDAR subunit at
Ser896 (Tyszkiewicz et al., 2004). We therefore tested whether a
similar phosphorylation of the GluN1 NMDAR subunit in re-
sponse to mGlu II receptor activation occurs in CA1 pyramidal
cells. Indeed, application of LY354740 (1 M, 10 min) increased
phosphorylation at GluN1 p-S896 in the CA1 region by 
70%
(LY354740, 1 M, 10 min: 173.3  18.5%, p 	 0.03, n 	 5; Fig.
2G,H) compared with control slices (no LY354740: n 	 7). This
increase in phosphorylation, observed in theWestern blots, was no
longer significantwhenmGlu II receptorswere activated inpresence
of a PKC inhibitor (bisindolylmaleimide, 1 M, 20 min; 143 
15.3%, p	 0.2, n	 7; Fig. 2G,H). We used a blocking peptide to
confirm the specificity of the anti-GluN1 phospho S896 antibody.
Therefore, activation of PKC by mGlu II receptors enhances
NMDAR function by increasing GluN1 phosphorylation.
mGlu2 andmGlu3 receptors activate synaptic and
extrasynaptic NMDARs differentially to promote
LTP induction
Depending on their subtype, mGlu receptors can be localized
perisynaptically and/or extrasynaptically, whereas NMDARs are
found both within and outside of the synapse. We performed
experiments to determine the contribution to mGlu II-receptor-
dependent LTP of NMDARs containing the GluN2B subunit,
which are primarily expressed outside of the synapse, and of re-
ceptors containing the GluN2A subunits, which represent the
majority of NMDARs within the synapse; the remainder corre-
spond to heterotrimeric receptors in adult rat hippocampus
(Papouin et al., 2012). Our results indicate a similar distribution
in adult mouse as blocking NR2B-containing receptors with
Ro25–6981 (3M) reducedEPSC amplitude by only 13.8 1.4%
(p	 0.02;n	 5), whereas subsequent addition ofNVP-AAM077
at 0.1M, the highest concentration that is still specific forNR2A-
containing receptors (Bartlett et al., 2007), reduced EPSC ampli-
tude by 63 4.9% (p 0.0001, n	 5; Fig. 3A). The remaining
response was blocked by D-AP5 (91.6  2.1%, p  0.0001,
n 	 5). The incomplete block with combined application of
NR2A and NR2B antagonists is likely to reflect the presence of
heterotrimeric receptors, which appear to be insensitive to
subunit-specific antagonists (Delaney et al., 2013).Under control
conditions, a similar reduction in mGlu II-dependent LTP
was observed with blockade of GluN2A subunit-containing
NMDARs (NVP-AAM077, 0.1 M, 20 min; 118.9  5.7%, p 	
0.028, n 	 7) as with blockade of GluN2B subunit-containing
NMDARs (Ro25–6981, 3 M, 20 min; 118.3 3.6%, p	 0.024,
n	 7; Fig. 3B,C). Selective inhibition of synaptic NMDARs with
the use-dependent antagonist MK-801 (40 M, 20 min) reduced
mGlu II-receptor-dependent LTP by more than half (118.4 
2.7%, p	 0.01, n	 7). Additional blockade of GluN2B subunit-
containing NMDARs by Ro25–6981 completely prevented LTP
(Ro25–6981, 3 M, 20 min; 106.4  2%, p 	 0.04, n 	 6; Fig.
3D,E). Conversely, blocking GluN2A-subunit-containing
NMDARs with NVP-AAM077 after MK-801 treatment did not
lead to a further reduction in LTP (NVP-AAM077, 0.1 M, 20
min; 116.5 4.6%, p	 0.9, n	 6; Fig. 3D,E). Therefore, mGlu
II receptors target both synaptic and extrasynaptic NMDARs to
trigger LTP (Fig. 3F).
We then used KO mice to assess the contribution of mGlu2
and mGlu3 receptors to LTP. mGlu II-receptor-dependent LTP
was reduced significantly in mGlu3 KOmice (121.0 1.7%, p	
0.03, n	 6), but not in mGlu2 KOmice (136.1 3.7%, p	 0.7,
n 	 7), compared with WT mice (141.1  6.7%, n 	 8; Fig.
3G,H). These findings indicate that activation of the mGlu2 re-
ceptor alone is not sufficient to induce maximal LTP compared
with mGlu3. Control experiments suggest that this effect is not
the consequence of mGlu II receptor KO causing a generalized
impairment in synaptic plasticity (Fig. 3 I, J). LTP induced by a
standard HFS protocol resulted in LTP of similar magnitude in
wild-type slices (167.1 26%, p	 0.04, n	 6), as in mGlu2 KO
(147.7  12.8%, p 	 0.01, n 	 5) and in mGlu3 KO slices
(154.5 6.2%, p	 0.001, n	 5).
It has been shown in several brain regions that postsynaptic
mGlu2 receptors are located at extrasynaptic sites remote
from the postsynaptic density, whereas postsynaptic mGlu3
receptors are expressed both synaptically and extrasynapti-
cally (Tamaru et al., 2001). This distinct distribution pattern
suggests that mGlu2 and mGlu3 receptors may differ in their
ability to modulate synaptic versus extrasynaptic pools of
NMDARs to induce LTP. We tested this hypothesis by exam-
ining the effects of blocking either GluN2A (mostly synaptic
NMDARs) or GluN2B (mostly extrasynaptic NMDARs)
subunit-containing NMDARs in mGlu2 and mGlu3 KO mice.
When the GluN2B subunit was blocked, mGlu II-receptor-
dependent LTP was reduced but still present in WT (118.3 
3.6%, n 	 7) and mGlu2 receptor KO slices (122.2  2.8%,
p	 0.64, n	 8), but was completely blocked in mGlu3 recep-
tor KO slices (104.6  2.7%, p 	0.023, n 	 6; Fig. 3K,L).
When the GluN2A subunit was blocked, mGlu II-receptor-
dependent LTP was reduced to a similar extent in WT
(118.9  5.7%, p 	 0.027, n 	 7), mGlu2 KO (121.1  3.3%,
p 	 0.018, n 	 8), and mGlu3 KO mice (120.9  1.1%, p 	
0.024, n	 6). These results are consistent with a scenario (Fig.
3M ) in which mGlu3 receptors can access both synaptic and
extrasynaptic NMDARs, whereas mGlu2 receptors modulate
only extrasynaptic NMDARs.
Comparing mGlu II-receptor-dependent LTP with HFS-LTP
Because mGlu II-receptor-dependent LTP and classical HFS-
LTP in the hippocampus are bothNMDAR dependent, we inves-
tigated whether they share similar mechanisms by performing
occlusion experiments. After stable pharmacological mGlu II-
induced LTP (138.4 6.6%, p	 0.01, n	 4; LY354740, 1M, 10
min; Fig. 4A,B), additional potentiation was induced by saturat-
ing HFS-LTP (3 trains at 100 Hz for 1 s with an interstimulus
interval of 20 s). The HFS-LTP protocol was repeated 3 times
with a 15 min interval to obtain saturating LTP (274.8 38.1%,
p	 0.037, n	 4; Fig. 4A,B). When the order was reversed, with
HFS-LTP (251.2  28.9%, n 	 4; Fig. 4C,D) preceding mGlu
II-receptor-dependent LTP, a further significant increase in LTP
was again observed (284.6 8.2%, p	 0.027, n	 4; Fig. 4C,D).
The mGlu II-receptor-dependent LTP and HFS-LTP do not oc-
clude each other. Moreover, as shown in Figure 4, E and G, in-
hibiting mGlu II receptors did not impair HFS-induced LTP
(control: 165.4 26.4%, n	 6; LY341495: 164.2 22.0%, n	 4,
p 	0.97), indicating that the HFS protocol does not activate
mGlu II receptors sufficiently to induce LTP. Together, these
results show that themGlu II-receptor-dependent LTP andHFS-
LTP do not share common induction mechanisms.
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Figure 3. Characterization of NMDAR subunits that are targeted by group II mGlu receptor subtypes to induce LTP in CA1 pyramidal cells. A, Pharmacologically isolated NMDA currents
(NBQX, 25 M) evoked by Schaffer collateral stimulation at a holding potential of70 mV with low extracellular magnesium (0.1 mM) were slightly diminished in the presence of a
GluN2B NMDAR subunit antagonist (Ro25– 69813, 3M, 20 min), but were strongly reduced after applying a GluN2A NMDAR subunit antagonist (NVP-AAM077, 0.1M, 20 min). Inset,
Sample traces of NMDA-EPSCs showing effects of antagonists (****p 0.0001, *p 0.05; ANOVA followed by Tukey’s post hoc test; F(3, 15)	 179.1). Scale bars, 25 ms and 40 pA. B, LTP
is significantly reduced in the presence of antagonists for either the GluN2A (NVP-AAM077, 0.1M, 20min) or the GluN2B NMDAR subunit (Ro25– 69813, 3M, 20min). C, Quantification
of fEPSP slope changes under the conditions presented in B. *p 0.05 indicates significantly different from slices treated with LY354740 alone (ANOVA followed by Tukey’s post hoc test;
F(2, 19)	 5.565). D, After bath application of the use-dependent blocker MK-801 (40M, 20 min) to block the synaptic NMDARs selectively, subsequent blocking of GluN2A subunits has
no further effect, whereas blocking of GluN2B subunits leads to an additional pronounced reduction in LTP. E, Quantification of fEPSP slope changes under the conditions presented in D.
*p 0.05 indicates significantly different from slices treated with LY354740 alone and MK801 (ANOVA followed by Tukey’s post hoc test; F(2, 16)	 3.799). F, Proposed scheme showing
the two different pools of NMDARs involved in the induction of LTP, one synaptic including mainly GluN2A subunits and the other extrasynaptic including mainly GluN2B subunits. G,
Comparison of group II mGlu-receptor-induced LTP in wild-type, mGlu2 KO, and mGlu3 KO mice shows that only the absence of the mGlu3 receptor reduces LTP. When mGlu2 and mGlu3
receptors are both blocked (LY341495, 4M, 10 min), LTP is prevented. H, Quantification of fEPSP slope changes under the conditions presented in G. *p 0.05 indicates significantly
different fromWTmice (ANOVA followed by Tukey’s post hoc test; F(2, 17)	 4.09). I, Single train of HFS induces LTP that was not significantly different in WT, mGlu2, andmGlu3 KO slices.
J, Quantification of fEPSP slope changes under the conditions presented in I (ANOVA followed by Tukey’s post hoc test; F(2, 13)	 0.2183). K, After blockade of the GluN2B NMDAR subunit,
LTP was prevented in mGlu3 KO mice and reduced in wild-type and mGlu2 KO mice. L, Quantification of fEPSP slope changes under the conditions presented in K. *p 0.05 indicates
significantly different from WT Ro25– 69813 mice (ANOVA followed by Tukey’s post hoc test; F(2, 18)	 7.927).M, Working model illustrating how distinct mGlu2 and mGlu3 receptor
localization may lead to preferential modulation of different pools of NMDARs, with only the mGlu3 receptor able to modulate both synaptic and extrasynaptic NMDARs. Scale bars for the
field traces: 0.5 mV and 10 ms.
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In the hippocampus, theta rhythm (5–14 Hz) is the dominant
neuronal oscillation and plays a crucial role in neuronal plasticity
to promote learning and memory. mGlu II receptor activation
contribute to the generation of hippocampal theta oscillations
(Ster et al., 2011).We investigatedwhethermGlu II-LTP could be
induced by a protocol of LFS in a theta range (80 pulses at 10Hz).
This protocol induced LTP (127.4 5.2%, p	 0.0066, n	 5; Fig.
4F,G) that was inhibited by the mGlu II receptor antagonist
LY341495 (101.3  4.6%, p 	 0.0098, n 	 4; Fig. 4F,G). These
results indicate that mGlu II–LTP can be induced by theta-
frequency oscillations.
Priming of NMDARs bymGlu II receptor activation
mediates metaplasticity
Our observation that activation of mGlu II receptors results in a
rapid increase within 5 min in the amplitude of NMDAR-
mediated EPSCs (Fig. 2E), but a much slower induction of LTP
(20 min) (Fig. 1A), suggests a metaplastic response (Abraham,
2008) whereby mGlu II-receptor-mediated modulation of
NMDARs enhances the generation of LTP.We further character-
ized this phenomenon by inducing subsaturating LTP with 1
train of HFS (100 Hz, 1 s) and comparing the response with or
without prior activation of mGlu II receptors (LY354740,1 M,
Figure 4. Twomodes of LTP induction, either by HFS or by group II mGlu receptor activation, do notmutually occlude each other.A, LTP induced by group II mGlu receptor activation (LY354740,
1 M, 10 min) reached a peak steady-state level after 45 min. At this point, HFS (3 trains at 100 Hz for 1 s separated by 20 s) repeated 3 times leads to a significant further increase in LTP.
B, Quantification of fEPSP slope changes under the conditions presented in A. Two-tailed paired Student’s t test. Left, Means for all slices. Right, Responses for each slice. C, In reverse order
experiments, HFSwas applied three times to achieve saturating LTP. Subsequent pharmacological activation of group II mGlu receptor activation induced a further increase in LTP.D, Quantification
of fEPSP slope changes under the conditions presented in C. Two-tailed paired Student’s t test. Left, Means for all slices. Right, responses for each slice. E, LTP induction by HFS (3 100 Hz, ISI: 20 s)
is not impaired by group II mGlu receptor antagonist (LY341495, 4M, 10 min). F, LTP induced by 80 pulses at 10 Hz is blocked by a group II mGlu receptor antagonist (LY341495, 4M, 10 min).
G, Quantification of fEPSP slope changes under the conditions presented in E and F. *p 0.05, **p 0.01, two-tailed unpaired Student’s t test. Scale bars, 0.5 mV and 10 ms.
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10 min). For these experiments, we did
not stimulate the Schaffer collateral path-
way during pharmacological activation
of mGlu II receptors. Pharmacological
priming resulted in a significant increase
in LTP (control: 32.8  5.1%, n 	 6;
priming: 65.4 5.5%, n	 7, p	 0.0014;
Fig. 5A,B). We then investigated whether
priming differs inWT andmGlu II recep-
tor KO mice. Priming, expressed as the
value of HFS-LTP with LY354740 nor-
malized to the value of HFS-LTP without
LY354740, had the greatest effect in WT
mice (111.5 9.8%, n	 6; Fig. 5C) and in
mGlu2 KOmice (86.3 10.1%, p	0.35,
n 	 6; Fig. 5C), but was significantly re-
duced in mGlu3 KOmice (53.2 15.5%,
p 	 0.013, n 	 6; Fig. 5C). This result is
consistent with the decrease in LTP ob-
served in the absence of the mGlu3
receptor (Fig. 3D,F). To gain insight into
the primingmechanism, we examined the
phosphorylation status of Ser-896 of the
GluN1 subunit of NMDARs during these
experiments. Activation ofmGlu II recep-
tors alone (LY354740, 1 M, 10 min) led
to almost a doubling of the phosphoryla-
tion level of GluN1 Ser896 (no stimula-
tion, no LY354740: n	 7; no stimulation
 LY354740: n 	 4, 198.7  36.3%,
p 	 0.026; Fig. 5D,E). Therefore, mGlu
II-receptor-mediated NMDAR phosp-
horylation does not require synaptic stim-
ulation. Therefore, NMDAR phosphory-
lation without synaptic stimulation is not
sufficient to induce LTP (Fig. 2A,B).
These findings are consistent with a prim-
ing role formGlu II receptors inwhich the
phosphorylation of NMDARs renders
synapses more competent to undergo
LTP.
Discussion
Our data show that selective activation of
mGlu II receptors at Schaffer collateral
synapses onto CA1 pyramidal neurons renders synapses more
competent for the induction of LTP through a mechanism in-
volving the phosphorylation of synaptic and extrasynaptic
NMDARs. Accumulating evidence suggests that group II mGlu
receptors are positively coupled to PLC/PKC pathways, in addi-
tion to the canonical adenylyl cyclase–PKA pathway. Previous
studies have demonstrated that activation of mGlu II receptors
can increase PLC activity in hippocampus (Klein et al., 1997) and
prefrontal cortex (Otani et al., 2002) and PKC activity in the
prefrontal cortex (Otani et al., 2002; Tyszkiewicz et al., 2004)
probably via the  complex of the Gi/o protein (Rebecchi and
Pentyala, 2000). Consistent with these data, we found that inhi-
bition of PKC completely blocked mGlu II-receptor-dependent
LTP. A similar PLC–PKC-dependent transduction mechanism
has been described at the parallel fiber–Purkinje cell synapse,
where activation ofmGlu4 receptors inhibits transmission (Abit-
bol et al., 2012), and in cultured cerebellar granule cells, where
mGlu7 receptor activation blocks P/Q-type calcium channels
(Perroy et al., 2000). Furthermore, PKC activation is typically a
calcium-dependent process, which is consistent with our obser-
vation that LTP initiated by mGlu II receptors was strongly re-
duced after depletion of intracellular calcium stores.
In our experiments, blockade of the adenylyl cyclase–PKA
pathway also reduced LTP, although to a lesser extent. Recent
studies suggest that the main role of the adenylyl cyclase–PKA
pathway in neurons is to modulate the functional expression of
mGlu II receptors. PKA can inhibit the dephosphorylation by
protein phosphatase 2C of Ser-845 in the C-terminal tail of the
mGlu3 receptor (Flajolet et al., 2003). Therefore, the interaction
of the mGlu3 receptor with the endocytic machinery may be
reduced, thereby stabilizing membrane expression as described
for other receptors (Chen and Roche, 2007). Alternatively,
PKA-mediated phosphorylation may enhance mGlu3-receptor-
initiated signal transduction (Uematsu et al., 2015). Therefore,
mGlu II receptors appear to signal both through inhibition of the
adenylyl cyclase–PKA pathway and through activation of a PLC–
Figure5. Pharmacological primingof group IImGlu receptors enhancesHFS-induced LTP.A, LTP inducedbyHFS (3 trains at 100
Hz for 1 s separated by 20 s) was potentiated by prior priming of group II mGlu receptors with LY354740 (1M, 10 min). Insets,
Representative traces (averages of six sweeps) before (1) and after (2) LTP induction. Scale bars, 0.5 mV and 10ms. B, Quantifica-
tion of fEPSP slope changes under the conditions presented in A. Two-tailed unpaired Student’s t test. C, Net increase in LTP after
primingwith LY354740 inWT,mGlu2KO, andmGlu3KOmice. LTP is significantly reduced inmGlu3KOmice comparedwithWTand
mGlu2 KOmice. ****p 0.0001, *p 0.05 indicates significantly different fromWTmice (ANOVA followed by Tukey’s post hoc
test; F(2, 15)	5.411).D,Westernblots showingphosphorylationat serine896of theGluN1 subunit (GluN1p-S896)underdifferent
conditions. The protein ladder shows molecular weight markers (M) in kDa. E, Protein quantification indicates greater levels of
phosphorylation at GluN1 p-S896 when group II mGlu receptors are activated even in the absence of stimulation, indicating that
both phosphorylation and activation of NMDARs are required to initiate plasticity. *p 0.05, **p 0.01, two-tailed unpaired
Student’s t test.
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PKC-dependent pathway. The enhancement of NMDAR-evoked
currents in CA1 pyramidal neurons in response tomGlu II recep-
tor activation has also been reported to involve Src tyrosine ki-
nase signaling (Trepanier et al., 2013). However, in a previous
study in pyramidal neurons of the prefrontal cortex (Tyszkiewicz
et al., 2004), as well as in our recordings from CA1 pyramidal
neurons, this effect could not be confirmed, possibly reflecting a
difference in experimental conditions. We found that mGlu II
receptor activation led to PKC-dependent phosphorylation of
the GluN1 subunit at Ser896 as described previously (Tyszkie-
wicz et al., 2004), which may account for the observed enhance-
ment in synaptic plasticity. We cannot, however, rule out an
involvement of PKC phosphorylation of GluN2A and GluN2B
subunits that could contribute to this effect.
Unlike classical NMDAR-dependent LTP, mGlu II-receptor-
dependent LTP exhibited a slow time course of potentiation. Be-
cause activation of mGlu II receptors mobilizes intracellular
Ca2 stores via IP3 transduction (Otani et al., 2002), the slow
kinetics of LTP may reflect a gradual rise in calcium. mGlu II
receptors may also act indirectly to increase intracellular calcium
by phosphorylating the GluN1 subunit, which can enhance cal-
cium influx through NMDARs by increasing the open probabil-
ity of the channel (Chen and Huang, 1992) and by promoting
receptor trafficking to the synapse (Lan et al., 2001; Groc et al.,
2004). In our experiments, the activation of mGlu II receptors
alone was insufficient to induce LTP; additional stimulation of
the Schaffer collateral pathway was required. This stimulation
depolarizes the targeted CA1 pyramidal cells, which, again, can
increase intracellular calcium influx by relieving magnesium
block from NMDAR channels (Mayer et al., 1984; Nowak et al.,
1984). Therefore, mGlu II receptor activation and CA1 pyrami-
dal cell depolarization can act synergistically to raise intracellular
calcium concentration to facilitate the induction of LTP (Ray-
mond and Redman, 2002; Cavazzini et al., 2005). Interestingly,
mGlu1 receptors also operate synergistically with NMDARs to
induce LTP at Schaffer collateral synapses by reducing the nega-
tive feedback regulation of SK channels on NMDA-receptor me-
diated currents (Tigaret et al., 2016).
Our results show that mGlu II-receptor-dependent LTP was
decreased significantly in mGlu3 receptor KO mice, but not in
mGlu2 receptor KO mice. These findings are likely to reflect the
differential somatodendritic localization of these receptors. Ex-
pression of mGlu2 receptors is not observed in the vicinity of the
synapse (Luja´n et al., 1997), suggesting that they modulate
an extrasynaptic pool of NMDARs preferentially. In contrast,
mGlu3 receptors are present both extrasynaptically and in the
proximity of the postsynaptic density (Tamaru et al., 2001),
which would allow them to act also on synaptic NMDARs. Our
experiments validate this scenario because LTPmediated by syn-
aptic GluN2A subunit-containing NMDARs was induced only
after activation of mGlu3 receptors, whereas LTP mediated by
extrasynaptic GluN2B subunit-containing NMDARs was ob-
served after activation of both mGlu2 and mGlu3 receptors. The
distinct spatial organization of mGlu II receptor subtypes may
also reflect specific interactions with scaffolding proteins (Paw-
son and Scott, 1997; Kim and Sheng, 2004). At present, however,
little information is available about these signal transduction
mechanisms except for the interaction of the mGlu3 receptor
with protein phosphatase 2C and PICK1 (Chung et al., 2000;
Hirbec et al., 2002).
Our experiments provide evidence for at least two distinct
mechanisms that contribute to mGlu II-receptor-dependent
LTP, one that operates through the priming of NMDARs and the
other through the release of intracellular calcium stores. There-
fore, mGlu II receptor activation in isolation does not induce
LTP, but rather exerts a metaplastic effect on NMDAR-mediated
synaptic plasticity, thereby altering the threshold for LTP induc-
tion (Abraham, 2008). The HFS protocol did not occlude mGlu
II-dependent LTP, which suggests that, in addition to NMDARs,
mGlu II receptors modulate further targets affecting synaptic
plasticity. An attractive candidate mechanism may involve an
action on inhibitory circuits because activation of hippocampal
mGlu II receptors has been shown to depress inhibitory transmis-
sion (Poncer et al., 1995) and to induce LTD at inhibitory syn-
apses (Liu et al., 1993), both of which could contribute to the
enhanced LTP that we observed.
Our experiments indicate that metaplasticity involving the
priming of NMDARs is mediated by the mGlu3 receptor. More-
over, consistent with our previous work showing the involve-
ment of mGlu3 receptors in the generation of theta oscillations
(Ster et al., 2011), we demonstrate that mGlu II-dependent LTP
can be induced by stimulation of Schaffer collaterals at theta
frequency. Theta oscillations are also implicated in the facilita-
tion of LTP generation in response to exposure to a novel envi-
ronment (Li et al., 2003). It is thus of interest that coactivation of
mGlu II receptors and NMDARs allows the induction of LTP in
response to patterns of stimulation that are more physiological
than the high-frequency trains used in classical LTP protocols.
Genetic and clinical studies have provided evidence for the
involvement of mGlu II receptors in schizophrenia (Patil et al.,
2007; Harrison et al., 2008), in which abnormal theta oscillations
have been reported (Ford et al., 2007). Given that schizophrenia
is characterized by a hypoglutamatergic state (Gao et al., 2000),
our finding that mGlu II receptors can act postsynaptically to
increaseNMDAR function suggests that their activationmay rep-
resent one of the mechanisms for the antipsychotic effects of
treatment with an mGlu2/3 agonist (Patil et al., 2007).
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